Scholars Central

CommentaryPublished 5 Feb 2011

Evaluation of myocardial injury and remodeling by nuclear medicine techniques

Authors: Walther Bild

Imaging in Medicine

Volume 3 · Issue 1 · Pages 9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Evaluation of: Higuchi T, Fukushima K, Xia J et al.: Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury. J. Nucl. Med. 51(12), 1956–1961 (2010). As important as the renin–angiotensin system (RAS) is in maintaining of blood pressure and hydroelectrolytic balance of the organism, it seems that any imbalance of normal homeostatic mechanisms can be further tipped by the unchecked actions of this system. These phenomena have been reunited under the generic name of ‘maladaptive mechanisms’, and their targeted imaging may provide insights into the evolution of disease, as well as identify possible therapeutic avenues. The present work introduces a new method of PET imaging of the angiotensin II type I receptors (AT1R) thought to be responsible for a series of maladaptive responses within the heart after a myocardial infarction (MI) in experimental animals (rats). The authors have used a specific AT1R ligand – KR 31173, tagged with ‘C’ as a specific PET tracer – for determining its potential use in evaluating the density of AT1R at the myocardial level and the evolution of its upregulation in the days following the MI. A series of very elaborate protocols have been developed for inducing an ischemiareperfusion lesion in the myocardium of the rats – identifying and properly documenting the extent of the scar tissue. These protocols used 201Tl chloride for the delineation of the nonperfused scar area and 99mTc-tetrofosmin for delineating the risk areas. The ex viva distribution of AT1R was measured by coupling saralasin– isoleucine–angiotensin II (125I-SI-ang II) – an angiotensin analog – to the flash-frozen heart sections. Region of interest analysis was performed on the Ang II activity, infarction scar (201Tl defect) and areas at risk (defect on 99mTc-tetrofosmin but not on 201Tl). After the administration of 11C-KR31173 (37MBq), the animals were sacrificed prior to autoradiography or kept alive for in vivo PET studies. The administration of 11CKR31173 was also made in the presence of a clinically approved angiotensin-converting enzyme (ACE-I) inhibitor – enalapril and of an angiotensin receptor blocker – valsartan. The in vivo PET scan was performed after injection of 11C-KR31173 in study groups and the control group, followed by injection of 13N-ammonia, for visualizing the myocardium and hypoperfused area. The results demonstrated that binding of 125I-SI was increased at 1 and 3 weeks in the infarcted territories, well matched with the infarction area as demonstrated by the 201Tl studies. The areas at risk, identified by 99mTc-tetrofosmin, showed no increase in the 125I-SI uptake. The same uptake pattern was demonstrated by 11C-KR31173, both in autoradiography studies and in the in vivo PET studies, with a maximum at 3 weeks after the MI. Administration of valsartan (angiotensin receptor blocker) partially (51%) blocked the 11C-KR31173 uptake, while enalapril (ACE-I) had no effect on the said parameter. The results demonstrated a clear increase in the expression of the AT1R in the infarcted areas, which seems to be responsible for the increased fibrosis and remodeling of the cardiac wall and the hemodynamic changes that lead to heart failure. It is known that activated myofibroblasts, which are the first cells to react after a MI, highly express AT1R and synthesize large amounts of collagen, thus contributing to the localized fibrosis. The present study also demonstrated that blockage of the AT1R, with its specific blocker valsartan, reduced the binding of the specific ligand, unlike the inhibition of Ang II synthesis with enalapril, which had no effect on 11C-KR31173 coupling. In summary, this was a very elegant and well-designed study, which was able to obtain several objectives: • Finally and definitively demonstrated localized increase of AT1R in infarcted areas of the myocardium; • Demonstrated the potential beneficial effect of angiotensin receptor blockers upon myocardial fibrosis and remodeling; • Validated a new PET-tracer – 11CKR31173 for evaluating the infarcted area and its evolution; • Introduced the notion that imaging might be helpful in the optimization of post-MI anti-RAS medication.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImaging in Medicine
  • SubjectRadiology & Imaging
  • BylineArticles whose byline prints “Walther Bild”